Novotech

ABOUT NOVOTECH

Founded in 1997, Novotech is a global full-service clinical Contract Research Organization (CRO) focused on partnering with biotech companies to accelerate the development of advanced and novel therapeutics at every phase.

Recognized for its industry-leading contributions, Novotech has received numerous prestigious awards, including the CRO Leadership Award 2023, the Asia Pacific Cell & Gene Therapy Clinical Trials Excellence 2023, the Asia-Pacific Contract Research Organization Company of the Year Award since 2006.

The Company offers a comprehensive suite of services including laboratories, Phase I facilities, drug development consulting, regulatory expertise, and has experience with over 5,000 clinical projects, including Phase I to Phase IV clinical trials and bioequivalence studies. With a presence in 34 office locations and a dedicated team of 3,000+ professionals worldwide, Novotech is a trusted end-to-end strategic partner of choice.

SERVICES

The Asia Pacific Biotech CRO With Global Execution Capabilities

Take advantage of the world’s fastest-growing clinical trials region to accelerate your global clinical development by leveraging Novotech’s global footprint, relationships, and infrastructure.
Novotech Drug Development Consulting: Services For Success

Delve into the details of this full-service global product development and strategic regulatory group that has a proven track record of successful FDA meetings and approvals.
Clinical Operations And Project Management For Every Phase

Get streamlined and integrated clinical trial services delivered by a dedicated team of professionals with deep industry and therapeutic area expertise across all phases of clinical development.
Biometrics And Data Management

Start getting accurate, high-quality, and timely biostatistics services delivered by this team of biostatisticians and statistical programmers, in addition to statistical planning, analysis, and reporting.
Patient Recruitment And Site Selection

Novotech relies on years of experience, in-country knowledge, and real-life big data to identify and propose the best-performing sites. Uncover the possibilities for your next study.
Oncology CRO Services

Biotechnology companies are facing increased challenges around participant recruitment and retention, lengthy timeframes, and relatively high costs.
Pharmacometric Services

Our talented and experienced team can assist in all Clinical Study Phases (Phase 0, I, II and III) and in study designs ranging from First in Human (FIH), Single Ascending Dose (SAD), Multiple Ascending Dose (MAD), Drug-Drug Interaction (DDI), Bioavailability/Bioequivalence (BA/BE), Food Effect as well as Special Population studies.
GMO Solutions

Novotech initiated the first national, privately owned, commercial Institutional Biosafety Committee (IBC) in Australia, successfully accredited by the Australian Office of the Gene Technology Regulator (OGTR).
Liver Disease CRO Services

Biotechnology companies consider locations in the Asia-Pacific region, such as South Korea and China to access vast treatment-naïve patient populations and accelerate their clinical trials at lower costs.
Infectious Diseases And Vaccines CRO Services

Many biotechnology companies look at the Asia-Pacific region for their trials in Infectious diseases and Vaccines due to the high prevalence of diseases such as Hepatitis (Hepatitis B, Hepatitis C), HIV, and Influenza across the region.
Orphan And Rare Disease CRO Services

There may be as many as 8,000 rare diseases, affecting between 6% and 8% of the worldwide population in total. It is estimated there are about 30 million affected people in the EU and in North America, while over 45 million people may be suffering from a rare condition in Asia, with 10 million people in China alone.

WEBINARS

Accelerating Development In Novel & Advanced Oncology Therapies

Hear from a panel of industry experts on dissecting the shift in early-phase oncology design, focusing on Bayesian Data.
Keeping Pace With The Evolving Global Landscape In Vaccine Development

Hear from a panel of life science experts about the most recent developments and ground-breaking approaches shaping the field of vaccine development worldwide.
The Biotech Landscape: Market Trends, Priorities, Predictions, And Pathways To FDA Approval

The webinar features regulatory affairs and investment leaders from North America and Asia Pacific who will discuss why biotech companies are increasingly exploring clinical opportunities in Asia Pacific to generate diverse, globally accepted clinical trial data, and much more.
Go/No Go Decisions Based On Early Phase Oncology Trials

In this webinar, gain insight into the latest regulatory and clinical developments in the field of oncology in China.
Development And Regulatory Strategy For US And China

This webinar discusses the expansion of International Market for Ensartini and RNAi Therapeutics in Oncology, from Skin Cancers to Liver Cancers.
Accelerating Clinical Development In China & The US

Discover how the clinical research bridge between China and the US supports accelerated clinical development from early to late phase trials while ensuring the inclusion of MRCT data packages in future regulatory applications.
Evolution Of Cell & Gene Therapy In China: The Case For Universal CAR-T

China now represents 60% of clinical development in CAR-T therapy development globally: what have we learned to date and where are future opportunities?

FEATURED REPORTS

Insights Into The Clinical Trials Landscape Of CL

Uncover developments in cystic fibrosis treatment, focusing on innovative drugs, ongoing clinical trials, and their potential impact on patient outcomes.
Global Prevalence And Clinical Trials Landscape Of AML

Explore the advancements in Acute Myeloid Leukaemia treatments, specifically innovative drugs, ongoing clinical trials, and their potential impact on patient outcomes.
Duchenne Muscular Dystrophy - Global Clinical Trial Landscape (2024)

Explore how this comprehensive approach can offer hope for improved outcomes and quality of life for DMD patients, highlighting global commitment to tackling this complex disorder.
Rheumatoid Arthritis – Global Clinical Trial Landscape

While RA presents a substantial global health challenge, see how evolving therapies and research efforts offer hope for improved outcomes and better management of this debilitating condition.
Global Prevalence And Clinical Trials Landscape Of DMD

Stay informed with the latest advancements in the fight against Duchenne Muscular Dystrophy, a disease that impacts thousands of lives worldwide.
Exploring Global Clinical Research Perspectives On RA Insights

Explore how the research into Rheumatoid Arthritis, which affects 17.6 million people worldwide, aims to improve treatment effectiveness and future interventions.
Insights Into Candidiasis: Global Clinical Research Overview

Explore how drug-resistant strains are posing challenges when it comes to the treatment of candidiasis, but therapeutic advancements and ongoing research are offering hope for improved outcomes.
Candidiasis – Global Clinical Trial Landscape

Get an overview of the diverse therapeutic modalities in drug development as it relates to the clinical trial landscape and prospects in Candidiasis treatment.
Pros And Cons Of Basing Clinical Trials In Today’s European Landscape

Explore the essential considerations for sponsors and CROs as they navigate the advantages and challenges of clinical trial locations, particularly in the United States and Europe.
Global Strides In HIV Research: Mapping The Clinical Trial Terrain

Uncover how ongoing research exploring innovative pathways is serving as a beacon of hope for HIV, promising not only an eventual cure but also an enhanced quality of life for those affected.
Metastatic Breast Cancer - Global Clinical Trial Landscape (2023)

Uncover why the collaboration between researchers, clinicians, regulatory bodies, and CROs remains crucial for innovative solutions and improved patient outcomes in the journey to address metastatic breast cancer challenges.
Dyslipidaemia – 2023 Global Clinical Trial Landscape

While APAC is at the forefront of dyslipidaemia research, gain insight into pharmaceutical companies' continued new treatment developments and innovative therapies.
Non-Small Cell Lung Cancer: Global Clinical Trial Landscape

Unearth how targeted medicines and immunotherapy have emerged as viable treatment options, offering hope for improved outcomes and quality of life for NSCLC patients.
Hemophilia - Global Clinical Trial Landscape

Delve into the clinical landscape of hemophilia, a rare X-linked congenital bleeding disorder, across three key regions of the globe, namely Asia Pacific, Europe, and North America.
Primary Biliary Cholangitis – 2023 Global Clinical Trial Landscape

See how the development of new drug classes offers the potential for better PBC management, addressing its global impact.
The State Of CAR-T Research In China

While numerous opportunities are available for companies seeking to undertake CAR-T research in China, understand why embarking on this path requires careful consideration.
Exploring Global Clinical Trends In Cell And Gene Therapy

Explore the exciting advancements in CNG treatment, such as innovative therapies, ongoing clinical trials, and their potential to positively influence patient outcomes.
The Challenges And Opportunities Of Virtual Clinical Trials

With ongoing technological advancements, consider several factors as to why experts believe that Virtual Clinical Trials will continue to play a significant role even beyond the post-pandemic era, despite its unique set of challenges.
The Future Of Clinical Trials: Embracing Virtualization, RQE, And AI

Delve into the swiftly evolving trends that are reshaping the clinical trial industry and examine potential implications for introducing innovative solutions to the market.
Going Global: How Working With A CRO Can Benefit Clinical Trials

Contract research organizations can be invaluable partners in clinical trials. Dive into the full spectrum of benefits you'll experience by partnering with a globally established and well-resourced CRO.
Advantages Of Including Europe And APAC Regions For Clinical Research

Discover the advantages of incorporating Europe and APAC regions in clinical trial endeavors, such as accelerated recruitment, streamlined regulatory procedures, access to diverse patient populations, and ultimately, significant cost reductions.
Antibody Drug Conjugates And The Global Research Landscape

Learn about ADCs advancements in cancer treatment and how the therapy could potentially revolutionize the field by reducing the often severe side effects associated with traditional chemotherapy.
Location Considerations For Successful Clinical Trials

Consider the advantages associated with conducting early- to late-phase clinical trials in China and the broader APAC region, as well as potential challenges that could impact the trial process and patient outcomes
Navigating The Evolving Pathways To FDA Approval

Gain insight into how teams can create clinical pathways and develop trial designs made for success.
An In-Depth Analysis Of CRO Operations And Impact On Drug Development

Get a full overview of the role CROs play in clinical trials and their impact on site selection, site monitoring, patient recruitment, managing data, and more.
Advancing Treatment Of Gallbladder Cancer

Get an overview of the exciting advancements in gallbladder cancer (GBC) treatment, emphasizing pioneering medications, ongoing clinical trials, and their potential to revolutionize patient outcomes.
Nasopharyngeal Carcinoma: Facts, Stats, And Research Updates

Explore exciting advancements in the treatment of nasopharyngeal carcinoma (NPC), specifically pharmaceuticals, ongoing clinical trials, and their potential to significantly improve patient prognosis and outcomes.
Crohn’s Disease – Global Clinical Trial Landscape - Focus On Asia Pacific

Dive into the global clinical trial landscape of Crohn's disease (CD), its trends in the Asia Pacific, and what the industry is doing to look for a cure.
Non-Hodgkin Lymphoma – Global Clinical Trial Landscape - Focus On Asia Pacific

Gain a better understanding of the global clinical trial landscape of Non-Hodgkin lymphoma (NHL) and its trends in the Asia Pacific.
Liver Cancer – Global Clinical Trial Landscape - Focus On Asia Pacific

Unearth how health officials are preparing to meet the rising demand for resources regarding liver cancer and ensure effective management throughout the cancer pathway.
Head and Neck Cancer – Global Clinical Trial Landscape - Focus On Asia Pacific

Get a full overview of the current clinical trial landscape as it relates to HNC and where treatment efforts are headed in the future.
Gallbladder Cancer: Global Clinical Trial Landscape

Uncover how pipeline drugs, especially small molecules, offer the potential to transform gallbladder cancer management, ultimately improving patient outcomes and addressing its global impact.
Nasopharyngeal Carcinoma: Global Clinical Trial Landscape

Read this report to better understand why a collaborative, multidisciplinary approach is essential to address NPC's complexities and achieve groundbreaking progress in its management.
The Compounding Benefits Of The Right Preclinical Development Approach

Traversing the so-called “valley of death” and forging a successful pathway to clinical development hinges on determining the optimal strategy for a product and indication.
The Cell & Gene Therapy Clinical Trials Global Landscape

Gain valuable insights into the current state of cell and gene therapy clinical trials and the opportunities and challenges in this rapidly evolving field.
What Are The Benefits Of A Well-Designed, Robust Preclinical Development Plan?

Discover how a well-designed and robust preclinical development plan can help identify potential safety and efficacy issues early in the drug development process, ultimately reducing the risk of failure in clinical trials.
Idiopathic Pulmonary Fibrosis: Global Clinical Trial Landscape - Focus On Asia Pacific

Learn about the incidence, distribution, and possible control of idiopathic pulmonary fibrosis (IPF) in the Asia Pacific region, in addition to the standard of care, current trial landscape, and more.
Alzheimer’s Disease: Global Clinical Trial Landscape - Focus On Asia Pacific

Gain a better understanding of the incidence, distribution, and possible control of Alzheimer’s disease (AD) in the Asia Pacific region, the standard of care, the trial landscape, and more.
Rheumatoid Arthritis: Global Clinical Trial Landscape - Focus On Asia Pacific

Gain a better understanding of the incidence, distribution, and possible control of rheumatoid arthritis (RA) in the Asia Pacific region, the standard of care, the trial landscape, and more.
Acute Myeloid Leukemia: Global Clinical Trial Landscape - Focus On Asia Pacific

Gain a better understanding of the incidence, distribution, and possible control of acute myeloid leukemia (AML) in the Asia Pacific region, the standard of care, the trial landscape, and more.
Prostate Cancer: Global Clinical Trial Landscape - Focus On Asia Pacific

Better understand the incidence, distribution, and possible control of prostate cancer (PCa) in the Asia Pacific region, the standard of care, the trial landscape, and more.
Breast Cancer: Global Clinical Trial Landscape - Focus On Asia Pacific

Better understand the incidence, distribution, and possible control of breast cancer in the Asia Pacific region, the standard of care, the trial landscape, and more.
Melanoma: Global Clinical Trial Landscape - Focus On Asia Pacific

Better understand the incidence, distribution, and possible control of melanoma in the Asia Pacific region, the standard of care, the trial landscape, and more.
Ovarian Cancer: Global Clinical Trial Landscape - Focus On Asia Pacific

Better understand the incidence, distribution, and possible control of ovarian cancer (OC) in the Asia Pacific region, the standard of care, the trial landscape, and more.
Why You Should Conduct Your Biotech And CAR-T Research In China

China is leading the world in oncology and CAR-T research. And with over a billion people and a government friendly to biotech, it’s an ideal location for international clinical trials.
Designing A Global Drug Development Program To Secure FDA Approval

Global clinical trials in the Asia-Pacific region are becoming an attractive solution for young biotech companies looking to utilize their capital efficiently and secure high-quality clinical data quickly.
Leveraging Global Drug Development Programs To Ensure Trial Success

Opting to take your biotech program global can help save crucial resources, produce high-quality clinical data for your therapy, and leverage unique regional advantages like region-specific indication strategies.
Parkinson's Disease: Asia Pacific Clinical Trial Landscape

In the coming years, the global burden of Parkinson's Disease (PD) is expected to rise. The number of people with PD in Asia is anticipated to exceed 6 million by 2030. Discover the factors leading to this in this report.
Multiple Myeloma: Asia Pacific Clinical Trial Landscape
COVID-19: Asia Pacific Clinical Trial Landscape

In December 2019, a novel coronavirus was discovered in China causing severe acute respiratory syndrome-like pneumonia which resulted in a pandemic. Find out more details regarding its spread in this report.

CONTACT INFORMATION

Novotech

Level 19, 66 Goulburn Street

Sydney, NSW 2000

AUSTRALIA

Request More Information

Visit Our Website

NEWS

FEATURED SOLUTIONS

CASE STUDIES

WHITE PAPERS

Cystic Fibrosis: Global Clinical Trial Landscape (2024)

Gain valuable insights on patient enrollment, site selection, and navigating global regulatory landscapes tailored to rare diseases, thus propelling forward CF research and treatment.
Acute Myeloid Leukaemia: Global Clinical Trial Landscape (2024)

Learn how the collaboration among researchers, healthcare providers, and pharmaceutical industries holds promise for progress in Acute Myeloid Leukaemia management and care.
Precision Oncology Clinical Trials And Statistics 2024

Delve into the latest advancements in clinical trials, targeted therapies, and the promising horizon of cancer care.
HIV – Global Clinical Trial Landscape

Get a comprehensive overview of the global HIV clinical trial landscape since 2018, showcasing regional leadership, trial phases, and growth rates.
Immune Checkpoint Inhibitors Global Clinical Trials Landscape (2023)

Dive into the forefront of immune checkpoint inhibitors clinical trials with an exploration of the latest trends and key findings.
Navigating The Biotech Landscape Amidst Covid-19 And Beyond

Access comprehensive insights and analysis for a deeper understanding of the biotech landscape, including optimism and challenges felt throughout 2023 and what the future could hold.
Infectious Diseases – 2018-2023 Global Clinical Trial Landscape

Gain in-depth insights into infectious diseases-based clinical trials and be better informed about trends, regional disparities, technological advancements, and financing dynamics.
Rare Disease – 2018-2022 Global Clinical Trial Landscape

Discover why the collaboration and expertise of organizations are vital in advancing rare disease research and improving the lives of millions affected.
Cell And Gene Therapies Global Clinical Trial Landscape (2018-2022)

Dive into how the advancements in technology are heralding a brighter future for patients worldwide, offering new hope and improved healthcare outcomes.
Oncolytic Virus Therapies – Global Clinical Trial Landscape - Focus On Asia Pacific

Explore the global landscape of oncolytic virus clinical trials, with a particular focus on trends in the Asia Pacific region.
RNA Therapies – Global Clinical Trial Landscape - Focus On Asia Pacific

Learn about the global clinical trial landscape of RNA therapy, with emphasis on trends in the Asia Pacific, and recent advancements in the field.
Phase I Trials Global Clinical Trial Landscape – Focus On Asia Pacific

Unearth key trends in global Phase I trials, including highlights from the top therapeutic areas, indications, and biologic drug types in popular trial regions of Asia Pacific, the United States, and Europe.
Global Outlook Of Multi-Specific Monoclonal Antibodies: Asia Pacific Focus

Learn about the global clinical trial landscape of multi-specific monoclonal antibodies (Mabs), with emphasis on trends in the Asia Pacific, and recent advancements in the field.
Capitalize On Regulatory Expertise To Simplify FDA Complexities

Get an overview of the global approval landscape, pathways to approval, and the importance of a robust clinical development program as made possible with the help of an experienced CRO.
Antibody Drug Conjugates: Global Trial Landscape - Focus On Asia Pacific

Gain a better understanding of the global clinical trial landscape of antibody drug conjugates (ADCs) and their trends in the Asia Pacific.
C3 Glomerulopathy: The Asia Pacific Clinical Trial Landscape

C3 Glomerulopathy (C3G) is a complex, rare complement-mediated renal disease. Find out its effects in the Asia Pacific.
Diabetic Retinopathy: The Asia Pacific Clinical Trial Landscape

Diabetic Retinopathy (DR) is the leading cause of vision loss in working-age populations, and one of the main complications of Diabetes Mellitus (DM). Read about the effects of this disease.
Opportunities For Ophthalmology Clinical Development In APAC: Glaucoma

The world is heavily burdened by glaucoma, which is the second-leading cause of blindness and the primary cause of irreversible blindness. Learn about its effects in the Asia Pacific.
Peanut Allergy: Asia Pacific Clinical Trial Landscape

Explore the differences between the common food allergies in Asia and the West, specifically the peanut allergy.
Paroxysmal Nocturnal HemoglobinuriaIn: The Asia Pacific Clinical Trial Landscape

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare condition that affects the ability of hematopoietic stem cells and their cellular offspring to bind specific proteins to the cell surface.
Top Therapeutic Areas In The Asia Pacific Clinical Trial Landscape

Explore why the Asia-Pacific region has emerged as a clinical trial hub due to the ease of regulatory compliance, low trial costs, rising patient population, and the availability of top clinical institutions as trial locations
Cell & Gene Therapy In The Asia Pacific Clinical Trial Landscape

Discover how a new class of therapeutics called cell and gene therapies are revolutionizing how diseases are treated and even potentially cured.
The Biotech Landscape: Opportunities In China And The Path To USFDA Approval

In this white paper, learn why western biopharma companies should take advantage of China’s revamped regulatory framework.
The Role Of Real World Evidence To Support US FDA And TGA Registrations

Real world evidence (RWE) can contribute valuable information to new medicine registrations, in particular, for diseases that are difficult to assess in randomized clinical trials (RCTs) and for emerging technologies.
Next Generation Sequencing In The Asia Pacific: The Availability & Reimbursement Landscape

Next generation sequencing (NGS) refers to a technology that detects genomic variation that is present at birth or emerges later in life. This report describes the availability of NGS in a selection of locations.
How Biotechs Are Using DCT Technology To Conduct Trials In The APAC Region

In this white paper, gain insight into how the Asia Pacific region, with its rapid growth of clinical trials, presents a great opportunity for conducting clinical research and has become the preferred destination for DCTs.
The Immuno-Oncology Clinical Trial Landscape In The Asia Pacific

Learn how the Asia Pacific has shown significant increase in Immuno-oncology (IO) trials between 2017 and 2021 and contributes to about 35% of clinical development in IO globally.
Clinical Development Strategies For Western Biotech Companies In China

Delve into how China is now more aligned with international standards, enabling biotech firms to streamline processes and timelines, which has significantly recharged biotech innovation.
Evolution Of Clinical Trials In The Asia Pacific Region

With changing global clinical trials landscape, explore how APAC is emerging as the hot spot for conducting clinical trials, especially in China.